Proceedings of the National Academy of Sciences, Volume 123, Issue 34, August 2026. SignificanceIntratumoral (IT) delivery of CXCL10 suppresses tumor growth and recurrence in murine models of head and neck squamous cell carcinoma by boosting recruitment of CD8+T, CD4+T, and NK cells into the tumor microenvironment. However, it does …